Evaluating Targeted Therapeutic Response With Predictive Blood-Based Biomarkers in Patients With Chronic Mild Traumatic Brain Injury

Evaluating Targeted Therapeutic Response With Predictive Blood-Based Biomarkers in Patients With Chronic Mild Traumatic Brain Injury

Chronic consequences of mild traumatic brain injury (mTBI) are heterogeneous, but may be treatable with targeted medical and rehabilitation interventions. A biological signature for the likelihood of response to therapy (i.e., ?predictive? biomarkers) would empower personalized medicine post-mTBI. T...

Full description

Bibliographic Details
Main Authors: Shawn R. Eagle, Ava M. Puccio, Denes V. Agoston, Ryan Soose, Michael Mancinelli, Rachel Nwafo, Peyton McIntyre, Allison Agnone, Savannah Tollefson, Michael Collins, Anthony P. Kontos, Walter Schneider, David O. Okonkwo
Format: Article
Language:English
Published: Mary Ann Liebert 2023-06-01
Series:Neurotrauma Reports
Subjects:
chronic mTBI
predictive biomarkers
p-tau
targeted treatment
UCH-L1
Online Access:https://www.liebertpub.com/doi/full/10.1089/NEUR.2023.0003

Internet

https://www.liebertpub.com/doi/full/10.1089/NEUR.2023.0003

Similar Items